QuidelOrtho Corp. (QDEL)
13.79
+0.27
(+2.00%)
USD |
NASDAQ |
Jun 26, 16:00
13.75
-0.04
(-0.29%)
After-Hours: 20:00
QuidelOrtho Cash from Financing (Quarterly) : 37.60M for March 31, 2026
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 37.60M |
| December 31, 2025 | -11.10M |
| September 30, 2025 | 46.00M |
| June 30, 2025 | 103.30M |
| March 31, 2025 | 17.60M |
| December 31, 2024 | -68.90M |
| September 30, 2024 | -26.30M |
| June 30, 2024 | 162.50M |
| March 31, 2024 | -18.50M |
| December 31, 2023 | -57.80M |
| September 30, 2023 | -48.70M |
| June 30, 2023 | -99.70M |
| March 31, 2023 | -59.60M |
| December 31, 2022 | -31.70M |
| September 30, 2022 | -126.00M |
| June 30, 2022 | 413.11M |
| March 31, 2022 | -3.408M |
| December 31, 2021 | -0.964M |
| September 30, 2021 | 1.756M |
| June 30, 2021 | -144.32M |
| March 31, 2021 | -29.65M |
| December 31, 2020 | -0.057M |
| September 30, 2020 | -43.20M |
| June 30, 2020 | -87.72M |
| March 31, 2020 | 0.705M |
| Date | Value |
|---|---|
| December 31, 2019 | -14.77M |
| September 30, 2019 | -5.957M |
| June 30, 2019 | -62.15M |
| March 31, 2019 | -14.68M |
| December 31, 2018 | -29.58M |
| September 30, 2018 | 2.989M |
| June 30, 2018 | -105.15M |
| March 31, 2018 | -111.80M |
| December 31, 2017 | 256.47M |
| September 30, 2017 | 9.89M |
| June 30, 2017 | 2.126M |
| March 31, 2017 | 2.121M |
| December 31, 2016 | 3.575M |
| September 30, 2016 | 2.546M |
| June 30, 2016 | 0.40M |
| March 31, 2016 | -23.32M |
| December 31, 2015 | -2.121M |
| September 30, 2015 | -14.51M |
| June 30, 2015 | -11.70M |
| March 31, 2015 | -0.356M |
| December 31, 2014 | 167.95M |
| September 30, 2014 | 1.006M |
| June 30, 2014 | 0.429M |
| March 31, 2014 | -1.326M |
| December 31, 2013 | 0.856M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Abbott Laboratories | 17.31B |
| Artivion, Inc. | 0.463M |
| Alphatec Holdings, Inc. | -1.774M |
| AtriCure, Inc. | -13.26M |
| Baxter International, Inc. | -11.00M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -33.00M |
| Cash from Investing (Quarterly) | -34.00M |
| Free Cash Flow | -159.40M |
| Free Cash Flow Per Share (Quarterly) | -0.9824 |
| Free Cash Flow to Equity (Quarterly) | -107.80M |
| Free Cash Flow to Firm (Quarterly) | -7.763M |
| Free Cash Flow Yield | -17.00% |